JENARRON THERAPEUTICS LIMITED

Active Newtownabbey

Manufacture of basic pharmaceutical products

0 employees website.com
Manufacture of basic pharmaceutical products
J

JENARRON THERAPEUTICS LIMITED

Manufacture of basic pharmaceutical products

Founded 27 Mar 2012 Active Newtownabbey, Northern Ireland 0 employees website.com
Manufacture of basic pharmaceutical products
Accounts Submitted 27 Jun 2025 Next due 30 Jun 2026 25 days remaining
Confirmation Submitted 17 Apr 2025 Next due 10 Apr 2026 2 months overdue
Net assets £-8K £22K 2024 year on year
Total assets £18K £3K 2024 year on year
Total Liabilities £25K £24K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

8 Dermont Crescent Newtownabbey BT36 4NZ Northern Ireland

Telephone

0800 000 0000

Website

www.example.com

Full company profile for JENARRON THERAPEUTICS LIMITED (NI611898), an active company based in Newtownabbey, Northern Ireland. Incorporated 27 Mar 2012. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2024
Type micro-entity
Next accounts 30 Sept 2025
Due by 30 Jun 2026 25 days remaining

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

N/A

Net Assets

-£7.78k

Decreased by £21.76k (-156%)

Total Liabilities

£25.31k

Increased by £24.34k (+2510%)

Turnover

N/A

Employees

N/A

Debt Ratio

144%

Increased by 138 (+2300%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
30 Sept Year End
2023
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 8 Shares £8 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 May 20168£8£1

Officers

Officers

3 active
Status
Mark Godfrey JenkinsDirectorBritishNorthern Ireland5927 Mar 2012Active
Norry McbrideDirectorBritishNorthern Ireland6414 Feb 2014Active
Paul Anthony MccarronDirectorBritishNorthern Ireland6027 Mar 2012Active

Shareholders

Shareholders (6)

Innovation Ulster Limited
33.6%
Sam Rusk
24.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

JENARRON THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Jun 2025AccountsAnnual accounts made up to 30 Sept 2024
17 Apr 2025Confirmation StatementConfirmation statement made on 27 Mar 2025 with no updates
24 Jun 2024AccountsAnnual accounts made up to 30 Sept 2023
10 Apr 2024Confirmation StatementConfirmation statement made on 27 Mar 2024 with no updates
27 Jun 2023AccountsAnnual accounts made up to 30 Sept 2022
27 Jun 2025 Accounts

Annual accounts made up to 30 Sept 2024

17 Apr 2025 Confirmation Statement

Confirmation statement made on 27 Mar 2025 with no updates

24 Jun 2024 Accounts

Annual accounts made up to 30 Sept 2023

10 Apr 2024 Confirmation Statement

Confirmation statement made on 27 Mar 2024 with no updates

27 Jun 2023 Accounts

Annual accounts made up to 30 Sept 2022

Recent Activity

Latest Activity

Annual accounts made up to 30 Sept 2024

11 months ago on 27 Jun 2025

Confirmation statement made on 27 Mar 2025 with no updates

1 years ago on 17 Apr 2025

Annual accounts made up to 30 Sept 2023

1 years ago on 24 Jun 2024

Confirmation statement made on 27 Mar 2024 with no updates

2 years ago on 10 Apr 2024

Annual accounts made up to 30 Sept 2022

2 years ago on 27 Jun 2023